Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-20-009289

Options or other derivatives

  • Chief Technical Officer acquired 112,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
HODGE GEOFFREY Chief Technical Officer 2020-02-11 Grant or award · Stock Option +112,400 112,400 D
Loading xslF345X03/doc4.xml…